Get App

WhatsApp Channel

Tune in to know the latest updates on the health industry

ETHealth Newsletters

Explore and Subscribe to our Daily Newsletters

Follow Us

Get updates of events and latest news from ETHealth on LinkedIn.

Dr Reddy's gets approval for anti-platelet drug in China

Clopidogrel is an anti-platelet drug that blocks platelets from sticking together and prevents them from forming harmful clots.
  • Published On Apr 25, 2019 at 05:34 PM IST
New Delhi: Drug firm Dr Reddy's Laboratories Thursday said it has received approval for anti-platelet drug Clopidogrel in China. "The company believes that the sales from this product will not be material in the current financial year, that is 2019-20," Dr Reddy's Laboratories said in a regulatory filing.

Clopidogrel is an anti-platelet drug that blocks platelets from sticking together and prevents them from forming harmful clots.

Shares of Dr Reddy's Laboratories Thursday closed at Rs 2,930 per scrip on the BSE, up 2.61 per cent from its previous close.
  • Published On Apr 25, 2019 at 05:34 PM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App
image